Testing effectiveness (Phase 2)Study completedNCT02262130
What this trial is testing
Omalizumab in Severe and Refractory Solar Urticaria
Who this might be right for
Solar Urticaria
Centre Hospitalier Universitaire de Besancon 10
Showing 3 of 3 results